The hallucinogens and the inhalants.
S Cohen
Psychiatric Clinics of North America December 1, 1984 DOI: 10.1016/s0193-953x(18)30722-6 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Peer reviewed |
|---|---|
| Topics | Ketamine LSD Mescaline Psilocybin |
| Keywords | Humans Substance-related disorders N,N-Dimethyltryptamine 3,4-methylenedioxyamphetamine Phencyclidine Hallucinogens Solvents Adolescent Dronabinol Dom 2,5-dimethoxy-4-methylamphetamine |
| Key points | The text characterizes hallucinogenic drugs as showing a recurrent outbreak pattern, with each generation or two seeming to rediscover their ego-dissolving effects, and describes inhalants as producing a short-lived intoxication in which certain volatile solvents affect specific organ systems. |
Abstract
The hallucinogenic drugs represent a recurrent outbreak pattern with each generation or two seeming to rediscover their ego-dissolving effects. The inhalants produce a short-lived intoxication with certain volatile solvents affecting specific organ systems.
Citations in the library
Cited by 3
- Occurrence and use of hallucinogenic mushrooms containing psilocybin alkaloids TemaNord May 19, 2009
- Within-subject comparison of the subjective and psychomotor effects of a gaseous anesthetic and two volatile anesthetics in healthy volunteers. Drug and Alcohol Dependence January 4, 2006
- Clinical features and management of intoxication due to hallucinogenic drugs. Medical toxicology and adverse drug experience 1989